The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors-Reference-Cited by-同舟云学术

The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors

Published:2016-06 Issue:11 Volume:26 Page:2622-2626
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Cox Jason M.,Chu Hong D.,Kuethe Jeffrey T.,Gao Ying-Duo,Scapin Giovanna,Eiermann George,He Huaibing,Li Xiaohua,Lyons Kathryn A.,Metzger Joseph,Petrov Aleksandr,Wu Joseph K.,Xu Shiyao,Sinha-Roy Ranabir,Weber Ann E.,Biftu Tesfaye

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference25 articles.

1. IDF Diabetes Atlas, 3rd ed.; International Diabetes Federation: Brussels, Belgium, 2013. http://www.idf.org/diabetesatlas/5e/the-global-burden.

2. Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005

3. Biology of Incretins: GLP-1 and GIP

4. The incretin system and its role in type 2 diabetes mellitus

5. Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants;Journal of Medicinal Chemistry;2023-08-30

2. Three Heterocyclic Rings Fused (5-6-5);Comprehensive Heterocyclic Chemistry IV;2022

3. A review upon medicinal perspective and designing rationale of DPP-4 inhibitors;Bioorganic & Medicinal Chemistry;2021-09

4. Recent Medicinal Chemistry Approach for the Development of Dipeptidyl Peptidase IV Inhibitors;Current Medicinal Chemistry;2021-06-10

5. In silico Studies on the Interaction Between Bioactive Ligands and DPPIV: Insights on Potential Candidates for the Treatment of type 2 Diabetes Mellitus;Medicinal Chemistry;2021-03